CTTN antibody: A302-607A


Antibody Info
Product_IDA302-607A
Lot_ID1
Host_organismrabbit
SourceBethyl Labs
Antibody_DCC_IDENCAB014AIG
Target Info
GeneNameCTTN
Phosphate
Target_nameCTTN-human

Validation Images
Cell linePrimary validationSecondary validation
HepG2 CTTN-HEPG2-CRISPR-A302-607A.png<br>Caption: Western blot following CRISPR against CTTN in HepG2 whole cell lysate using CTTN specific antibody. Lane 1 is a ladder, lane 2 is HepG2 non-targeting control knockdown, lane 3 and 4 are two different CRISPR against CTTN. CTTN protein appears as the green arrow, Beta-actin serves as a control and appears in red arrow.

Caption: Western blot following CRISPR against CTTN in HepG2 whole cell lysate using CTTN specific antibody. Lane 1 is a ladder, lane 2 is HepG2 non-targeting control knockdown, lane 3 and 4 are two different CRISPR against CTTN. CTTN protein appears as the green arrow, Beta-actin serves as a control and appears in red arrow.

Releated Sample: BGHcLV29-51

Status: Released

Lab: Graveley Lab

K562 Bethyl_A302-607A_1_CTTN.png<br>Caption: IP-WB analysis of K562 whole cell lysate using the CTTN specific antibody, A302-607A. Lanes 1 and 2 are 2.5% of five million whole cell lysate input and 50% of IP enrichment, respectively, using a normal IgG antibody. Lane 3 is 50% of IP enrichment from five million whole cell lysate using the CTTN-specific antibody, A302-607A. The same antibody was used to detect protein levels via Western blot. This antibody passes preliminary validation and will be further pursued for secondary validation. *NOTE* Protein sizes are taken from Genecards.org and are only estimates based on sequence. Actual protein size may differ based on protein characteristics and electrophoresis method used.

Caption: IP-WB analysis of K562 whole cell lysate using the CTTN specific antibody, A302-607A. Lanes 1 and 2 are 2.5% of five million whole cell lysate input and 50% of IP enrichment, respectively, using a normal IgG antibody. Lane 3 is 50% of IP enrichment from five million whole cell lysate using the CTTN-specific antibody, A302-607A. The same antibody was used to detect protein levels via Western blot. This antibody passes preliminary validation and will be further pursued for secondary validation. *NOTE* Protein sizes are taken from Genecards.org and are only estimates based on sequence. Actual protein size may differ based on protein characteristics and electrophoresis method used.

Comments: Immunoprecipitation lane (3) exhibits a large deviation from the expected protein size, which we believe is due to performing the characterization using the Jess Western Blotting system. This system has a documented tendency for some proteins to run differently than with more traditional methods due to their compositions and interactions with the electrophoretic components. The image also closely resembles the example image provided by the vendor but secondary validation will be needed for verification.

Method: immunoprecipitation

Status: Released

Lab: Yeo Lab

CTTN-K562-CRISPR-A302-607A.png<br>Caption: Western blot following CRISPR against CTTN in K562 whole cell lysate using CTTN specific antibody. Lane 1 is a ladder, lane 2 is K562 non-targeting control knockdown, lane 3 and 4 are two different CRISPR against CTTN. CTTN protein appears as the green arrow, GAPDH serves as a control and appears in red arrow.

Caption: Western blot following CRISPR against CTTN in K562 whole cell lysate using CTTN specific antibody. Lane 1 is a ladder, lane 2 is K562 non-targeting control knockdown, lane 3 and 4 are two different CRISPR against CTTN. CTTN protein appears as the green arrow, GAPDH serves as a control and appears in red arrow.

Releated Sample: BGKcLV28-51

Status: Released

Lab: Graveley Lab